Preemptive Therapy vs Antiviral Prophylaxis and CMV in Seronegative Liver Transplant Recipients With Seropositive Donors
This randomized trial compares preemptive therapy vs antiviral prophylaxis with valganciclovir in cytomegalovirus (CMV)-seronegative liver transplant recipients with seropositive donors for the prevention of CMV disease.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cytomegalovirus | General Medicine | Liver | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology